Fund

MSA Capital

和玉资本

MSA Capital (和玉资本) is a China-based venture capital firm that has participated in several notable growth-stage deals in the technology and healthcare sectors. Per a 2022 高榕创投 piece, it joined the $200 million Series B round for Vitaeon Therapeutics (Sironax), a biotech company developing therapies for aging-related degenerative diseases . It also followed on in Biren Technology's Series B round in 2021, a general-purpose intelligent chip design company, per 源码资本 , and was among the investors in Sand.ai's dual-round raise exceeding $100 million in mid-2026, again per 源码资本 .

elsewhere's corpus does not contain foundational details about MSA Capital's own structure — such as its founding year, fund size, or core investment thesis — beyond these deal participations.

AI-generated — may contain errors, please verify.

MSA CapitalFund
和玉资本
渲染中…
Mentioned in 7 articles

Coverage